Nano-X Imaging Ltd.

NNOX Healthcare Medical Devices

Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 36.7%, EPS fell 243.5%, free cash flow fell 21.4% and total debt fell 12.0%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

0.45 0.04 −8.16%
Market cap
$38.6M
P/E
0.0×
Fwd P/E
−2.9×
Dividend yield
—
F-score
3/9
Altman Z
−0.16
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

3 3 4 3
ROE
(34.75%) (45.62%) (50.12%) (98.98%)
ROA
(30.95%) (40.31%) (44.40%) (84.82%)
ROIC
(31.48%) (52.17%) (57.58%) (168.62%)
Return on Tangible Assets
(65.02%) (94.27%) (112.22%) (205.34%)
Average Days of Receivables
57.47 56.43 55.54 44.06
Free Cash Flow per Share
(0.70) (0.69) (0.72) (0.74)
Free Cash Flow
(45.27) (45.00) (49.88) (52.09)
Other line items

Show all line items

Columns are period end dates